TMCnet News
H+ Transporting Two Sector ATPase Pipeline Report 2016: Therapeutics Review of 2 Companies & 6 Molecules - Research and MarketsResearch and Markets has announced the addition of the "H+ Transporting Two Sector ATPase (F1F0 ATP Synthase or ATP Synthase or Mitochondrial ATPase or Bacterial Ca2+/Mg2+ ATPase or EC 3.6.3.14) - Pipeline Review, H2 2016" report to their offering. H+ Transporting Two Sector ATPase is an important enzyme that creates the energy storage molecule adenosine triphosphate (ATP (News - Alert)). The majority of cellular energy in the form of adenosine triphosphate (ATP) is synthesized by the ubiquitous F1F0 ATP synthase. Power for ATP synthesis derives from an electrochemical proton (or Na+) gradient, which drives rotation of membranous F0 motor components. H+ Transporting Two Sector ATPase pipeline Target (News - Alert) constitutes close to 6 molecules. Out of which approximately 5 molecules are developed by Companies and remaining by the Universities/Institutes. The molecules developed by Companies in Pre-Registration, Phase II, Preclinical and Discovery stages are 1, 1, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinial stages comprises 1 molecule, respectively. H+ Transporting Two Sector ATPase - Pipeline Review, H2 2016, outlays comprehensive information on the H+ Transporting Two Sector ATPase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in H+ Transporting Two Sector ATPase targeted therapeutics development, features dormant and discontinued projects and latest news and press releases. Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/6grrs2/h_transporting
View source version on businesswire.com: http://www.businesswire.com/news/home/20161011005826/en/ |
